Abstract
With a worldwide incidence of approximately 200,000 new cases and a mortality of 102,000 patients each year renal cell carcinoma (RCC) accounts for approximately 4% of cancer incidence and 2% of cancer mortality. Over the last decades the incidence of RCC has risen, largely due to the widespread use of cross-sectional imaging. Incidentally found small renal masses (SRMs,
| Original language | English |
|---|---|
| Qualification | Doctor of Philosophy |
| Awarding Institution |
|
| Supervisors/Advisors |
|
| Award date | 12 Jun 2012 |
| Publisher | |
| Print ISBNs | 978-94-6191-318-0 |
| Publication status | Published - 12 Jun 2012 |
Fingerprint
Dive into the research topics of 'Renal cellcarcinoma: advances in minimally invasive treatments and outcome prediction'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver